FDA inspection
Betco Corp Ltd: FDA inspection ending Jan 14, 2000
FDA inspection 10309 · Voluntary Action Indicated (VAI) · Bowling Green, OH
Key facts
| Inspection ID | 10309 |
|---|---|
| Firm | Betco Corp Ltd |
| FEI number | 1000638666 |
| Address | 400 Van Camp Rd |
| City | Bowling Green |
| State | OH |
| ZIP | 43402-9062 |
| Fiscal year | 2000 |
| Inspection end date | Jan 14, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation |
| Product type | Drugs, Food/Cosmetics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data